Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus.
about
Targeting the RAS oncogene.Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas.Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas.Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms.Paclitaxel-loaded polyphosphate nanoparticles: a potential strategy for bone cancer treatment
P2860
Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus.
@ast
Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus.
@en
type
label
Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus.
@ast
Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus.
@en
prefLabel
Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus.
@ast
Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus.
@en
P2860
P356
P1476
Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus.
@en
P2093
Vicki L Keedy
P2860
P304
P356
10.2147/OTT.S19055
P407
P577
2012-08-22T00:00:00Z